Núñez, Julio http://orcid.org/0000-0003-1672-7119
Núñez, Eduardo
Revuelta-López, Elena
Miñana, Gema
Barallat, Jaume
Bodi, Vicent
Sanchis, Juan
Aimo, Alberto
Emdin, Michele
Lupón, Josep
Husser, Oliver
Bayes-Genis, Antoni
Funding for this research was provided by:
Instituto de Salud Carlos III (PIE15/00013, PIE15/00013, PIE15/00013, PIE15/00013)
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (16/11/00420, 16/11/00420, 16/11/00420, 16/11/00420)
Article History
Received: 7 November 2020
Accepted: 2 March 2021
First Online: 15 March 2021
Competing interests
: Julio Núñez has received speaker fees from Novartis, Vifor Pharma, Boehringer Ingelheim, Astra Zeneca, Rovi, and Novonordisk. The other authors have no disclosures.